Antimitochondrial antibodies and antibodies to extractable nuclear antigens in patients with primary biliary cirrhosis
Descripción del Articulo
Objective: To determine the frequency of antimitochondrial antibodies and antibodies to extractable nuclear antigens in patients with primary biliary cirrhosis. Methods: Cross-sectional study carried-out in the Servicio de Inmunología del Hospital Nacional Arzobispo Loayza from January 2018 to March...
| Autores: | , |
|---|---|
| Formato: | artículo |
| Fecha de Publicación: | 2020 |
| Institución: | Universidad Peruana Cayetano Heredia |
| Repositorio: | Revistas - Universidad Peruana Cayetano Heredia |
| Lenguaje: | español |
| OAI Identifier: | oai:revistas.upch.edu.pe:article/3770 |
| Enlace del recurso: | https://revistas.upch.edu.pe/index.php/RMH/article/view/3770 |
| Nivel de acceso: | acceso abierto |
| id |
REVUPCH_878ea269d4fe1a0aa85633ba11e335dc |
|---|---|
| oai_identifier_str |
oai:revistas.upch.edu.pe:article/3770 |
| network_acronym_str |
REVUPCH |
| network_name_str |
Revistas - Universidad Peruana Cayetano Heredia |
| repository_id_str |
|
| spelling |
Antimitochondrial antibodies and antibodies to extractable nuclear antigens in patients with primary biliary cirrhosisAnticuerpos antimitocondriales y anticuerpos contra antígenos extraíbles del núcleo en pacientes con cirrosis biliar primariaOliva Menacho, José EnriqueOliva Candela, Jose ArturoObjective: To determine the frequency of antimitochondrial antibodies and antibodies to extractable nuclear antigens in patients with primary biliary cirrhosis. Methods: Cross-sectional study carried-out in the Servicio de Inmunología del Hospital Nacional Arzobispo Loayza from January 2018 to March 2019. Clinical charts of 30 patients with presumptive clinical features of primary biliary cirrhosis were reviewed. We used an immunologic blood kit and an immunofluorescence microscopy at 40K to detect antinuclear antibodies and antimitochondrial antibodies, an immunoblot was used to detect antibodies to extractable nuclear antigens. Results: 30 patients were included in the study, 20 were female (66.7%). The most frequent stain pattern was the cytoplasmic reticular mottled pattern; 17 (56.7%) followed by the mottled pattern, 7 (23.3%) and the least frequent pattern was the centromeric pattern. Nine patients (42.9%) with primary biliary cirrhosis had anti-M2. Most of the patients with primary biliary cirrhosis had antimitochondrial antibodies 21(70%). Conclusions: We found a high frequency of the cytoplasmic reticular mottled pattern among patients with primary biliary cirrhosis and an association with anti-M2 and with antimitochondrial antibodies.Objetivo: Determinar la frecuencia de anticuerpos antimitocondriales y de anticuerpos contra antígenos extraíbles del núcleo en pacientes con cirrosis biliar primaria. Material y métodos: Estudio de tipo cuantitativo, observacional y transversal, realizado en el Servicio de Inmunología del Hospital Nacional Arzobispo Loayza entre enero 2018 y marzo 2019. Se revisaron las historias clínicas de 30 pacientes con características presuntivas de cirrosis biliar primaria; para la detección de los anticuerpos antinucleares y anticuerpos antimitocondriales se empleó el kit inmunológico en sangre y observación con microscopio de inmunofluorescencia a 40X y para la detección de los anticuerpos contra antígenos extraíbles del núcleo se empleó el método Immunoblot. Resultados: Se estudiaron 30 pacientes con cirrosis biliar primaria, 20 fueron de sexo femenino (66,7%). El patrón de tinción más frecuente fue el citoplasmático moteado reticular en 17(56,7%), seguido del patrón citoplasmático moteado reticular y patrón moteado en 7(23,3%) pacientes, y en menor frecuencia el patrón citoplasmático moteado reticular y patrón centromérico. Nueve (42,9%) pacientes con cirrosis biliar primaria tenían anti-M2. Se demostró mayor frecuencia, 21(70%) de los pacientes con cirrosis biliar primaria tenían anticuerpos antimitocondriales. Conclusiones: Se encontró alta frecuencia de patrón citoplasmático moteado reticular en pacientes con cirrosis biliar primaria, se demostró asociación significativa con los anti-M2 y anticuerpos antimitocondriales.Universidad Peruana Cayetano Heredia2020-07-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-reviewed articleArtículo evaluado por paresapplication/pdfhttps://revistas.upch.edu.pe/index.php/RMH/article/view/377010.20453/rmh.v31i2.3770Revista Médica Herediana; Vol. 31 No. 2 (2020): April - June; 95-100Revista Médica Herediana; Vol. 31 Núm. 2 (2020): Abril - Junio; 95-100Revista Medica Herediana; v. 31 n. 2 (2020): Abril - Junio; 95-1001729-214X1018-130Xreponame:Revistas - Universidad Peruana Cayetano Herediainstname:Universidad Peruana Cayetano Herediainstacron:UPCHspahttps://revistas.upch.edu.pe/index.php/RMH/article/view/3770/4199info:eu-repo/semantics/openAccessoai:revistas.upch.edu.pe:article/37702020-07-31T20:25:14Z |
| dc.title.none.fl_str_mv |
Antimitochondrial antibodies and antibodies to extractable nuclear antigens in patients with primary biliary cirrhosis Anticuerpos antimitocondriales y anticuerpos contra antígenos extraíbles del núcleo en pacientes con cirrosis biliar primaria |
| title |
Antimitochondrial antibodies and antibodies to extractable nuclear antigens in patients with primary biliary cirrhosis |
| spellingShingle |
Antimitochondrial antibodies and antibodies to extractable nuclear antigens in patients with primary biliary cirrhosis Oliva Menacho, José Enrique |
| title_short |
Antimitochondrial antibodies and antibodies to extractable nuclear antigens in patients with primary biliary cirrhosis |
| title_full |
Antimitochondrial antibodies and antibodies to extractable nuclear antigens in patients with primary biliary cirrhosis |
| title_fullStr |
Antimitochondrial antibodies and antibodies to extractable nuclear antigens in patients with primary biliary cirrhosis |
| title_full_unstemmed |
Antimitochondrial antibodies and antibodies to extractable nuclear antigens in patients with primary biliary cirrhosis |
| title_sort |
Antimitochondrial antibodies and antibodies to extractable nuclear antigens in patients with primary biliary cirrhosis |
| dc.creator.none.fl_str_mv |
Oliva Menacho, José Enrique Oliva Candela, Jose Arturo |
| author |
Oliva Menacho, José Enrique |
| author_facet |
Oliva Menacho, José Enrique Oliva Candela, Jose Arturo |
| author_role |
author |
| author2 |
Oliva Candela, Jose Arturo |
| author2_role |
author |
| description |
Objective: To determine the frequency of antimitochondrial antibodies and antibodies to extractable nuclear antigens in patients with primary biliary cirrhosis. Methods: Cross-sectional study carried-out in the Servicio de Inmunología del Hospital Nacional Arzobispo Loayza from January 2018 to March 2019. Clinical charts of 30 patients with presumptive clinical features of primary biliary cirrhosis were reviewed. We used an immunologic blood kit and an immunofluorescence microscopy at 40K to detect antinuclear antibodies and antimitochondrial antibodies, an immunoblot was used to detect antibodies to extractable nuclear antigens. Results: 30 patients were included in the study, 20 were female (66.7%). The most frequent stain pattern was the cytoplasmic reticular mottled pattern; 17 (56.7%) followed by the mottled pattern, 7 (23.3%) and the least frequent pattern was the centromeric pattern. Nine patients (42.9%) with primary biliary cirrhosis had anti-M2. Most of the patients with primary biliary cirrhosis had antimitochondrial antibodies 21(70%). Conclusions: We found a high frequency of the cytoplasmic reticular mottled pattern among patients with primary biliary cirrhosis and an association with anti-M2 and with antimitochondrial antibodies. |
| publishDate |
2020 |
| dc.date.none.fl_str_mv |
2020-07-31 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Peer-reviewed article Artículo evaluado por pares |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://revistas.upch.edu.pe/index.php/RMH/article/view/3770 10.20453/rmh.v31i2.3770 |
| url |
https://revistas.upch.edu.pe/index.php/RMH/article/view/3770 |
| identifier_str_mv |
10.20453/rmh.v31i2.3770 |
| dc.language.none.fl_str_mv |
spa |
| language |
spa |
| dc.relation.none.fl_str_mv |
https://revistas.upch.edu.pe/index.php/RMH/article/view/3770/4199 |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Universidad Peruana Cayetano Heredia |
| publisher.none.fl_str_mv |
Universidad Peruana Cayetano Heredia |
| dc.source.none.fl_str_mv |
Revista Médica Herediana; Vol. 31 No. 2 (2020): April - June; 95-100 Revista Médica Herediana; Vol. 31 Núm. 2 (2020): Abril - Junio; 95-100 Revista Medica Herediana; v. 31 n. 2 (2020): Abril - Junio; 95-100 1729-214X 1018-130X reponame:Revistas - Universidad Peruana Cayetano Heredia instname:Universidad Peruana Cayetano Heredia instacron:UPCH |
| instname_str |
Universidad Peruana Cayetano Heredia |
| instacron_str |
UPCH |
| institution |
UPCH |
| reponame_str |
Revistas - Universidad Peruana Cayetano Heredia |
| collection |
Revistas - Universidad Peruana Cayetano Heredia |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1853763013901811712 |
| score |
12.686729 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).